F1ANNEX IIILIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED
1.Anti-infectious agents
1.1.Chemotheurapeutics
1.1.2.Benzenesulphonamides
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Clorsulon | Clorsulon | Bovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
150 μg/kg | Liver | ||||
400 μg/kg | Kidney |
1.2.Antibiotics
1.2.1.Beta-lactamase inhibitors
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Clavulanic acid | Clavulanic acid | Bovine, ovine | 200 μg/kg | Milk | F10Provisional MRLs expire on 1 July 2001 |
Bovine, ovine, porcine | 200 μg/kg | Muscle | |||
200 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
200 μg/kg | Kidney |
1.2.2.Macrolides
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
F4Acetylisovaleryltylosin | Sum of acetylisovaleryltylosin and 3-O-acetyltylosin | Porcine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
100 μg/kg | Skin and fat | ||||
100 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
Erythromycin | MRLs apply to all microbiological active residues expressed as erythromycin equivalent | Bovine, ovine | 40 μg/kg | Milk | Provisional MRLs expire on 1 June 2000 |
Bovine, ovine, porcine, poultry | 400 μg/kg | Muscle | |||
400 μg/kg | Fat | ||||
400 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
Poultry | 200 μg/kg | Eggs | |||
Josamycin | Josamycin | Chicken | 200 μg/kg | Muscle | F14Provisional MRLs expire on 1.7.2002 |
200 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
200 μg/kg | Eggs | ||||
Sum of the microbiologically active metabolites, expressed as josamycin | Porcine | 200 μg/kg | Muscle | Provisional MRLs expire on 1.7.2002 | |
200 μg/kg | Skin and fat | ||||
200 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
F8Tilmicosin | Tilmicosin | Bovine | 40 μg/kg | Milk | Provisional MRLs expire on 1.1.2001 |
F11Tulathromycin | (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2- ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa- 6-azacyclopent-decan-15-one expressed as tulathromycin equivalents | Bovine | 100 μg/kg | Fat | Provisional MRLs expire on 1 July 2004; not for use in animals from which milk is produced for human consumption |
3 000 μg/kg | Liver | ||||
3 000 μg/kg | Kidney | ||||
Porcine | 100 μg/kg | Skin and fat | Provisional MRLs expire on 1 July 2004 | ||
3 000 μg/kg | Liver | ||||
3 000 μg/kg | Kidney |
F71.2.4.Cephalosporins
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Cefacetrile | Cefacetrile | Bovine | 125 μg/kg | Milk | F15Provisional MRLs expire on 1.1.2002 For intrammamary use only |
F5Cefalonium | Cefalonium | Bovine | 10 μg/kg | Milk | F16Provisional MRLs expire on 1.1.2003 |
F13Cefoperazone | Cefoperazone | Bovine | 50 μg/kg | Milk | Provisional MRLs expire on 1 January 2001 |
F17Cefquinome | Cefquinome | Porcine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2000 |
50 μg/kg | Skin + fat | ||||
100 μg/kg | Liver | ||||
200 μg/kg | Kidney | ||||
Cephapirin | Sum of cephapirin and desacetylcephapirin | Bovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
10 μg/kg | Milk |
1.2.5.Aminoglycosides
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Aminosidine | Aminosidine | Bovine, porcine, rabbits, chicken | 500 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
1 500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
Apramycin | Apramycin | Bovine | 1 000 μg/kg | Muscle | Provisional MRLs expire on 1 July 1999 |
For use in non-lactating cattle only | 1 000 μg/kg | Fat | |||
10 000 μg/kg | Liver | ||||
20 000 μg/kg | Kidney | ||||
Porcine | 1 000 μg/kg | Muscle | |||
1 000 μg/kg | Skin and fat | ||||
1 000 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
F18Dihydrostreptomycin | Dihydrostreptomycin | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1.6.2002 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
200 μg/kg | Milk | ||||
Porcine | 500 μg/kg | Muscle | |||
500 μg/kg | Skin and fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
Gentamicin | Gentamicin | Bovine | 100 μg/kg | Milk | Provisional MRLs expire on 1.6.2002 |
Bovine, porcine | 50 μg/kg | Muscle | |||
50 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
750 μg/kg | Kidney | ||||
F6Kanamycin | Kanamycin | Rabbits | 100 μg/kg | Muscle | F19Provisional MRLs expire on 1.1.2004 |
100 μg/kg | Fat | ||||
600 μg/kg | Liver | ||||
2 500 μg/kg | Kidney | ||||
Bovine, ovine | 100 μg/kg | Muscle | |||
100 μg/kg | Fat | ||||
600 μg/kg | Liver | ||||
2 500 μg/kg | Kidney | ||||
150 μg/kg | Milk | ||||
Porcine, chicken | 100 μg/kg | Muscle | |||
100 μg/kg | Skin + fat | ||||
600 μg/kg | Liver | ||||
2 500 μg/kg | Kidney | ||||
F18Neomycin (including framycetin) | Neomycin B | Bovine, porcine, chicken | 500 μg/kg | Muscle | Provisional MRLs expire on 1.6.2002 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
Bovine | 500 μg/kg | Milk | |||
Chicken | 500 μg/kg | Eggs | |||
Spectinomycin | Spectinomycin | Bovine | 200 μg/kg | Milk | Provisional MRLs expire on 1 July 2000 |
Bovine, porcine, poultry | 300 μg/kg | Muscle | |||
500 μg/kg | Fat | ||||
2 000 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
Ovine Not for use in animals from which milk is produced for human consumption | 300 μg/kg | Muscle | Provisional MRLs expire on 1.1.2002 | ||
500 μg/kg | Fat | ||||
2 000 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
Chicken | 200 μg/kg | Eggs | |||
F18Streptomycin | Streptomycin | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1.6.2002 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
200 μg/kg | Milk | ||||
Porcine | 500 μg/kg | Muscle | |||
500 μg/kg | Skin and fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney |
1.2.6.Quinolones
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
F12Danofloxacin | Danofloxacin | Porcine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.1.2000 |
50 μg/kg | Skin and fat | ||||
200 μg/kg | Liver | ||||
200 μg/kg | Kidney | ||||
Decoquinate | Decoquinate | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
500 μg/kg | Kidney | ||||
F9Difloxacin | Difloxacin | Bovine Not for use in animals from which milk is produced for human consumption | 400 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
100 μg/kg | Fat | ||||
1 400 μg/kg | Liver | ||||
800 μg/kg | Kidney | ||||
Porcine | 400 μg/kg | Muscle | |||
100 μg/kg | Skin and fat | ||||
800 μg/kg | Liver | ||||
800 μg/kg | Kidney | ||||
Enrofloxacin | Sum of enrofloxacin and ciprofloxacin | Ovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1 July 1999 |
100 μg/kg | Fat | ||||
300 μg/kg | Liver | ||||
200 μg/kg | Kidney | ||||
Flumequine | Flumequine | Bovine, ovine, porcine, chicken | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
50 μg/kg | Fat or skin and fat | ||||
100 μg/kg | Liver | ||||
300 μg/kg | Kidney | ||||
Salmonidae | 150 μg/kg | Muscle and skin | |||
Marbofloxacin | Marbofloxacin | Bovine | 150 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
50 μg/kg | Fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
75 μg/kg | Milk | ||||
Porcine | 150 μg/kg | Muscle | |||
50 μg/kg | Skin and fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
Oxolinic acid | Bovine31 | 100 µg/kg | Muscle | ||
50 µg/kg | Fat | ||||
150 µg/kg | Liver | ||||
150 µg/kg | Kidney | ||||
Porcine | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
Chicken | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
50 μg/kg | Eggs | ||||
Fin fish | 300 μg/kg | Muscle and skin in natural proportions | |||
Provisional MRLs expire 1 January 2006. | |||||
Not for use in animals from which milk is produced for human consumption. |
1.2.9.Polymyxins
Phamarcologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Colistin | Colistin | Bovine, ovine | 50 μg/kg | Milk | F14Provisional MRLs expire on 1.7.2002 |
Bovine, ovine, porcine, chicken, rabbits | 150 μg/kg | Muscle | |||
150 μg/kg | Fat | ||||
150 μg/kg | Liver | ||||
200 μg/kg | Kidney | ||||
Chicken | 300 μg/kg | Eggs |
1.2.10.Penicillins
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
F7Nafcillin | Nafcillin | Bovine | 300 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
300 μg/kg | Fat | ||||
300 μg/kg | Liver | ||||
300 μg/kg | Kidney | ||||
30 μg/kg | Milk | ||||
Penethamate | Benzylpenicillin | Ovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
4 μg/kg | Milk | ||||
Porcine | 50 μg/kg | Muscle | |||
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney |
1.2.11.Florfenicol and related compounds
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Florfenicol | Sum of florfenicol and its metabolites measured as florfenicol-amine | Fish | 1 000 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 July 2001 |
F7Thiamphenicol | Thiamphenicol | Ovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
Porcine | 50 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
Fin fish | 50 μg/kg | Muscle and skin in natural proportions |
F121.2.12.Polypeptides
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Bacitracin | Bacitracin | Bovine | 150 μg/kg | Milk | Provisional MRLs expire on 1.7.2001 |
F71.2.13.Lincosamides
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Lincomycin | Lincomycin | Ovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
50 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
150 μg/kg | Milk | ||||
Porcine | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
Chicken | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
50 μg/kg | Eggs | ||||
F12Pirlimycin | Pirlimycin | Bovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.7.2000 |
100 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
100 μg/kg | Milk |
F51.2.14.Pleuromutilines
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Tiamulin | Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin | Turkey | 100 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
100 μg/kg | Skin and fat | ||||
300 μg/kg | Liver |
Substituted by Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin.